1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer

Technology appraisal guidance [TA668] Published date: 06 January 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact report PDF 282.99 KB 06 January 2021  
  • Resource impact template Excel 1.44 MB 06 January 2021  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance